Durai Rajaraman, Ng Philip C H, Hoque Happy
Department of Surgery at University, Hospital Lewisham, London, England.
AORN J. 2010 May;91(5):599-606; quiz 607-9. doi: 10.1016/j.aorn.2009.11.065.
Methicillin-resistant Staphylococcus aureus (MRSA) is a serious threat to patients in health care facilities and the community. A MRSA infection can be much more severe than other bacterial infections and can be life-threatening. Resistance to common antibiotics makes treating MRSA costly and difficult. Prolonged hospitalization requiring specialized IV antibiotics also has cost implications. Treatment of MRSA can include use of antibiotics; topical therapies such as honey, topical silver, and gentian violet; and bacteriophages. Research is being conducted on new antibiotics and a MRSA vaccine.
耐甲氧西林金黄色葡萄球菌（MRSA）对医疗机构和社区中的患者构成严重威胁。MRSA感染可能比其他细菌感染严重得多，甚至可能危及生命。对常用抗生素的耐药性使得治疗MRSA既昂贵又困难。需要使用专门的静脉注射抗生素进行长期住院治疗也会产生费用问题。MRSA的治疗方法包括使用抗生素；局部疗法，如蜂蜜、局部用银和龙胆紫；以及噬菌体。目前正在对新型抗生素和MRSA疫苗进行研究。
